Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Sep '25 Sep 28, 2025	Dec '24 Dec 29, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 2, 2022	Jan '21 Jan 3, 2021	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Labs Revenue	1.47B	1.43B
Immunohematology Revenue	539.50M	522.60M
Donor Screening Revenue	60.60M	115.50M
Transfusion Medicine Revenue	600.10M	638.10M
Point of Care Revenue	613.20M	694.10M
Molecular Diagnostics Revenue	24.80M	24.00M
Revenue (Other)	3.70M	-
Revenue (Total)	2.71B	2.78B

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Sep '25 Sep 28, 2025	Dec '24 Dec 29, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 2, 2022	Jan '21 Jan 3, 2021	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
North America Adjusted EBITDA	-	892.10M
EMEA Adjusted EBITDA	-	46.50M
China Adjusted EBITDA	-	130.50M
Other Geographies Adjusted EBITDA	-	133.50M
Corporate Adjusted EBITDA	-	-659.70M
Operating Income (Total)	-953.30M	-1.96B

Updated Sep 28, 2025. Data Source: Fiscal.ai.